# Guoxin Pharmaceutical Technology (Beijing) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guoxin-pharmaceutical-technology-beijing-co

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.gxcro.com
- Total disclosed funding: $45M
- Latest round: Series B (Dec 13, 2022)
- Investors on record: 8

## About

Established in 2008 and based in Beijing, China, Guoxin Pharmaceutical Technology (Beijing) Co., Ltd., also known as GX Pharma is a contract research organization (CRO) pharmaceuticals research and development company that focuses on clinical research services and registration solutions for drugs, biological products, and medical devices. It has 7 subsidiaries, 23 offices, and 3 overseas branches, with more than 500 employees as far as 2021. It has cooperated with 700 tertiary hospitals, 500 clinical research institutions, 160 pharmaceutical companies, and has completed more than 280 clinical trials. The company has a number of honors, such as Top 20 Outsourcing Companies in China's Pharmaceutical Industry for consecutive three years, high-tech enterprise. 

The company provides pharmaceutical research and development and clinical research services. Specific services include medical affairs, post-market research, vaccine clinical research, registration declaration, site management organization, and etc.

The company plans to improve the layout of the industrial chain, expand the business scope, and expand the research and operation team.

## Funding rounds

- Series B, Dec 13, 2022, $14M — In Capital, Guangzhou Guoju Venture Capital, Shenzhen Qianhai Beizeng Asset Management, Ruize Investment
- Series B, Oct 26, 2021, $16M — PricewaterhouseCoopers, Puhua Capital, JHF Investment
- Angel, Sep 24, 2020, $15M — In Capital
- Seed, Jun 1, 2018 — Wuming Venture

## Investors

- Wuming Venture (https://capitalatlas.ai/funds/wuming-venture) — Seed
- In Capital — Angel, Series B
- PricewaterhouseCoopers — Series B
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series B
- JHF Investment (https://capitalatlas.ai/funds/jhf-investment) — Series B
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Series B
- Shenzhen Qianhai Beizeng Asset Management (https://capitalatlas.ai/funds/shenzhen-qianhai-beizeng-asset-management) — Series B
- Ruize Investment — Series B